No upregulation of digitalis glycoside receptor (Na,K-ATPase) concentration in human heart left ventricle samples obtained at necropsy after long term digitalisation
- PMID: 1655269
- DOI: 10.1093/cvr/25.8.684
No upregulation of digitalis glycoside receptor (Na,K-ATPase) concentration in human heart left ventricle samples obtained at necropsy after long term digitalisation
Abstract
Study objective: The aim was to evaluate the hypothesis that digitalis glycosides increase the concentration of their specific receptor (Na,K-ATPase) in human myocardial tissue, thereby possibly reducing the inotropic effect of long term digitalis treatment.
Design: Intact samples of left ventricle were obtained at necropsy from patients who had been on long term treatment with digoxin and from patients not previously given digoxin. Digitalis glycoside receptors were quantified using vanadate facilitated 3H-ouabain binding before and after washing samples in buffer containing excess digoxin antibody fragments for 16 h at 30 degrees C. This washing procedure has previously been shown to reduce prior specific digoxin binding in human left ventricle by 95% and to allow subsequent vanadate facilitated complete quantification of 3H-ouabain binding sites. In this context it was performed to reduce occupancy of digitalis glycoside receptors by digoxin, caused by digitalisation before 3H-ouabain binding.
Subjects: 11 patients who had been on long term treatment with digoxin and eight who had not previously been given digoxin were studied. Left ventricle samples were obtained at necropsy at around 15 h after death.
Measurements and main results: Standard 3H-ouabain binding was 39% less in samples from digitalised than from undigitalised subjects (p less than 0.001). Washing samples in buffer containing excess digoxin antibody fragments induced an increase in 3H-ouabain binding from 174(SEM 10) to 265(20) pmol.g-1 wet weight (n = 11, p less than 0.001) in samples from digitalised patients. After washing, the digitalis glycoside receptor concentration in left ventricle samples showed a tendency to a lower value (14%, p greater than 0.10) in patients exposed to digoxin compared to left ventricle samples from individuals unexposed to digitalis glycoside treatment. Calculating 3H-ouabain binding relative to dry ventricular muscle weight confirmed the results obtained using wet weight as reference.
Conclusions: The results suggest that digoxin treatment in life is associated with a 34% occupancy of digitalis glycoside receptors with digoxin. In the human heart there was no evidence for upregulation of digitalis glycoside receptor concentration due to long term digitalisation. Thus at receptor level there was no evidence for development of tolerance to digoxin therapy. The lower digitalis glycoside receptor concentration in the left ventricle observed in the heart failure patients may support the report of a relationship between Na,K-ATPase concentration as evaluated by 3H-ouabain binding and left ventricular function.
Similar articles
-
Human myocardial Na,K-ATPase concentration in heart failure.Mol Cell Biochem. 1996 Oct-Nov;163-164:277-83. doi: 10.1007/BF00408668. Mol Cell Biochem. 1996. PMID: 8974067 Review.
-
No adaptation to digitalization as evaluated by digitalis receptor (Na,K-ATPase) quantification in explanted hearts from donors without heart disease and from digitalized recipients with end-stage heart failure.Am J Cardiol. 1993 Jan 1;71(1):110-4. doi: 10.1016/0002-9149(93)90720-w. Am J Cardiol. 1993. PMID: 8380532
-
Human skeletal muscle digitalis glycoside receptors (Na,K-ATPase)--importance during digitalization.Cardiovasc Drugs Ther. 1993 Feb;7(1):175-81. doi: 10.1007/BF00878327. Cardiovasc Drugs Ther. 1993. PMID: 8387326
-
Enhanced clearance of specifically bound digoxin from human myocardial and skeletal muscle samples by specific digoxin antibody fragments: subsequent complete digitalis glycoside receptor (Na,K-ATPase) quantification.J Cardiovasc Pharmacol. 1991 Apr;17(4):670-7. doi: 10.1097/00005344-199104000-00022. J Cardiovasc Pharmacol. 1991. PMID: 1711637
-
Clinical Use of Digitalis: A State of the Art Review.Am J Cardiovasc Drugs. 2018 Dec;18(6):427-440. doi: 10.1007/s40256-018-0292-1. Am J Cardiovasc Drugs. 2018. PMID: 30066080
Cited by
-
Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.J Am Coll Cardiol. 2019 Aug 6;74(5):617-627. doi: 10.1016/j.jacc.2019.05.064. J Am Coll Cardiol. 2019. PMID: 31370952 Free PMC article.
-
Myocardial Na,K-ATPase: Clinical aspects.Exp Clin Cardiol. 2003 Fall;8(3):131-3. Exp Clin Cardiol. 2003. PMID: 19641704 Free PMC article.
-
Human myocardial Na,K-ATPase concentration in heart failure.Mol Cell Biochem. 1996 Oct-Nov;163-164:277-83. doi: 10.1007/BF00408668. Mol Cell Biochem. 1996. PMID: 8974067 Review.
-
Oral digoxin effects on exercise performance, K+ regulation and skeletal muscle Na+ ,K+ -ATPase in healthy humans.J Physiol. 2022 Aug;600(16):3749-3774. doi: 10.1113/JP283017. Epub 2022 Aug 2. J Physiol. 2022. PMID: 35837833 Free PMC article. Clinical Trial.
-
Reduced 3H-ouabain binding site (Na,K-ATPase) concentration in ventricular myocardium of dogs with tachycardia induced heart failure.Basic Res Cardiol. 1993 Nov-Dec;88(6):607-20. doi: 10.1007/BF00788878. Basic Res Cardiol. 1993. PMID: 8147825
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources